Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Does the clinical course of depression determine improvement in symptoms and quality of life?

Moses T, Leuchter AF, Cook I, Abrams M.

J Nerv Ment Dis. 2006 Apr;194(4):241-8.

PMID:
16614544
2.

Significant improvement in the quality of life of Brazilian depressed outpatients 12 weeks following the start of antidepressants.

Berlim MT, Pargendler J, Brenner J, Fleck MP.

Psychiatry Res. 2007 Dec 3;153(3):253-9. Epub 2007 Aug 1.

PMID:
17675247
3.

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.

Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.

J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.

PMID:
19027961
4.

Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant.

Krell HV, Leuchter AF, Morgan M, Cook IA, Abrams M.

J Clin Psychiatry. 2004 Sep;65(9):1174-9.

PMID:
15367043
5.

Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.

Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE.

J Clin Psychiatry. 2006 May;67(5):761-70.

PMID:
16841626
6.

Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.

Demyttenaere K, Andersen HF, Reines EH.

Int Clin Psychopharmacol. 2008 Sep;23(5):276-86. doi: 10.1097/YIC.0b013e328303ac5f.

PMID:
18703937
7.

Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER.

Reed C, Monz BU, Perahia DG, Gandhi P, Bauer M, Dantchev N, Demyttenaere K, Garcia-Cebrian A, Grassi L, Quail D, Tylee A, Montejo AL.

J Affect Disord. 2009 Mar;113(3):296-302. doi: 10.1016/j.jad.2008.05.021. Epub 2008 Jul 7.

PMID:
18603303
8.

Can sociodemographic and clinical variables predict the quality of life of outpatients with major depression?

Berlim MT, McGirr A, Fleck MP.

Psychiatry Res. 2008 Sep 30;160(3):364-71. doi: 10.1016/j.psychres.2007.07.024. Epub 2008 Aug 19.

PMID:
18715654
9.

Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode.

Pintor L, Baillès E, Valldeoriola F, Tolosa E, Martí MJ, de Pablo J.

Gen Hosp Psychiatry. 2006 Jan-Feb;28(1):59-64.

PMID:
16377367
10.
11.

The clinical relevance of changes in the Montgomery-Asberg Depression Rating Scale using the minimum clinically important difference approach.

Duru G, Fantino B.

Curr Med Res Opin. 2008 May;24(5):1329-35. doi: 10.1185/030079908X291958 . Epub 2008 Mar 28.

PMID:
18377706
12.
13.

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW.

J Clin Psychopharmacol. 2008 Dec;28(6):631-7. doi: 10.1097/JCP.0b013e31818a6cea.

PMID:
19011431
14.

Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.

van Calker D, Zobel I, Dykierek P, Deimel CM, Kech S, Lieb K, Berger M, Schramm E.

J Affect Disord. 2009 Apr;114(1-3):243-53. doi: 10.1016/j.jad.2008.07.023. Epub 2008 Oct 11.

PMID:
18849079
15.

A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.

Septien-Velez L, Pitrosky B, Padmanabhan SK, Germain JM, Tourian KA.

Int Clin Psychopharmacol. 2007 Nov;22(6):338-47.

PMID:
17917552
16.

[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

Gourion D.

Encephale. 2008 Jan;34(1):73-81. doi: 10.1016/j.encep.2007.12.001. Epub 2008 Feb 5. Review. French.

PMID:
18514154
17.

Baseline severity of depression predicts antidepressant drug response relative to escitalopram.

Kilts CD, Wade AG, Andersen HF, Schlaepfer TE.

Expert Opin Pharmacother. 2009 Apr;10(6):927-36. doi: 10.1517/14656560902849258 .

PMID:
19317630
18.
19.
20.

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

Papakostas GI, Fava M.

Eur Neuropsychopharmacol. 2009 Jan;19(1):34-40. doi: 10.1016/j.euroneuro.2008.08.009. Epub 2008 Sep 26. Review.

PMID:
18823760

Supplemental Content

Support Center